These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34497137)

  • 1. Chromogranin A Deficiency Confers Protection From Autoimmune Diabetes via Multiple Mechanisms.
    Srivastava N; Hu H; Vomund AN; Peterson OJ; Baker RL; Haskins K; Teyton L; Wan X; Unanue ER
    Diabetes; 2021 Dec; 70(12):2860-2870. PubMed ID: 34497137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.
    Baker RL; Bradley B; Wiles TA; Lindsay RS; Barbour G; Delong T; Friedman RS; Haskins K
    J Immunol; 2016 Jan; 196(1):39-43. PubMed ID: 26608914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice.
    Nikoopour E; Cheung R; Bellemore S; Krougly O; Lee-Chan E; Stridsberg M; Singh B
    Eur J Immunol; 2014 Apr; 44(4):1170-80. PubMed ID: 24443235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice.
    Nikoopour E; Sandrock C; Huszarik K; Krougly O; Lee-Chan E; Masteller EL; Bluestone JA; Singh B
    J Immunol; 2011 Apr; 186(7):3831-5. PubMed ID: 21357258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes.
    Bergot AS; Buckle I; Cikaluru S; Naranjo JL; Wright CM; Zheng G; Talekar M; Hamilton-Williams EE; Thomas R
    J Immunol; 2020 Apr; 204(7):1787-1797. PubMed ID: 32111734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
    Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
    Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.
    Yamanouchi J; Verdaguer J; Han B; Amrani A; Serra P; Santamaria P
    J Immunol; 2003 Dec; 171(12):6900-9. PubMed ID: 14662897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery.
    Liu B; Hood JD; Kolawole EM; Woodruff DM; Vignali DA; Bettini M; Evavold BD
    Diabetes; 2020 Mar; 69(3):381-391. PubMed ID: 31806623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation in the autoimmune diabetes of the NOD mouse.
    Unanue ER
    Annu Rev Immunol; 2014; 32():579-608. PubMed ID: 24499272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse.
    Unanue ER; Ferris ST; Carrero JA
    Immunol Rev; 2016 Jul; 272(1):183-201. PubMed ID: 27319351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
    Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
    J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.
    Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD
    J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Mitchell JS; Spanier JA; Dwyer AJ; Knutson TP; Alkhatib MH; Qian G; Weno ME; Chen Y; Shaheen ZR; Tucker CG; Kangas TO; Morales MS; Silva N; Kaisho T; Farrar MA; Fife BT
    Immunity; 2024 Oct; 57(10):2399-2415.e8. PubMed ID: 39214091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice.
    Carrero JA; McCarthy DP; Ferris ST; Wan X; Hu H; Zinselmeyer BH; Vomund AN; Unanue ER
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10418-E10427. PubMed ID: 29133420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and therapeutic control of diabetogenic CD8+ T cells.
    Santamaria P
    Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
    Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
    J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.
    Kanagawa O; Militech A; Vaupel BA
    J Immunol; 2002 Jun; 168(12):6159-64. PubMed ID: 12055228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.
    Nikoopour E; Krougly O; Lee-Chan E; Haeryfar SM; Singh B
    Clin Exp Immunol; 2016 Sep; 185(3):292-300. PubMed ID: 27185276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A is an autoantigen in type 1 diabetes.
    Stadinski BD; Delong T; Reisdorph N; Reisdorph R; Powell RL; Armstrong M; Piganelli JD; Barbour G; Bradley B; Crawford F; Marrack P; Mahata SK; Kappler JW; Haskins K
    Nat Immunol; 2010 Mar; 11(3):225-31. PubMed ID: 20139986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.